Taiwan Liposome Company, Ltd.
NASDAQ: TLC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Keelung Hong
- Headquarters
- Taipei, Taiwan
- IPO year
- 2018
- Website
- http://www.tlcbio.com
Loading TLC…
Loading profile data…Frequently asked questions about TLC
Where does TLC trade?
Taiwan Liposome Company, Ltd. (TLC) trades on the NASDAQ Global Market.
What sector is TLC in?
Taiwan Liposome Company, Ltd. (TLC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Taiwan Liposome Company, Ltd.?
Keelung Hong is the chief executive officer of Taiwan Liposome Company, Ltd. (TLC).
Where is Taiwan Liposome Company, Ltd. headquartered?
Taiwan Liposome Company, Ltd. is headquartered in Taiwan.
Does TLC pay a dividend?
Taiwan Liposome Company, Ltd. (TLC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TLC go public?
Taiwan Liposome Company, Ltd. (TLC) completed its initial public offering in 2018.
Is TLC an ADR?
Yes — TLC is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Taiwan Liposome Company, Ltd. reporting and dividends follow the underlying issuer.